Purpose

The purpose of this study is to examine the effect of a moderately low blood sugar stress on the nervous system. The investigators hope that information obtained from completing this study will help to reveal information about how a non-psychological stress impacts the parts of the brain that react to stress and the autonomic nervous system. The autonomic nervous system is the part of the nervous system that provides the body with involuntary or automatic control of heart rate, blood pressure, and breathing.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 45 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy volunteers - Males and Females age 18 to 45 years - BMI 18-35 kg/m2

Exclusion Criteria

  • Pregnancy - Lactation - Menopause - Any medical condition - Current or prior alcohol or drug abuse - Active tobacco use - Abnormal ECG - In all subjects, any individuals on oral, injected, inhaled or topical corticosteroids within the last year or oral contraceptives within the past 3 months will be excluded. - Use of medications other than thyroid hormone or hormonal birth control - Serum potassium >5.0 mmol/L - Estimated GFR <60 mL/min/1.73 m2 - Hemoglobin A1c ≥6.5% - Patient Health Questionnaire (PHQ9) for depression score ≥15 - GAD-7 Questionnaire for anxiety score ≥10 - PTSD Checklist for DSM-5 (PCL-5) score ≥31 - Perceived Stress Scale (PSS-14) score >28 - Blood pressure systolic ≥140 or <100 mmHg; Blood pressure diastolic >90 mmHg - Metal in the body including: cardiac pacemakers, stents, artificial heart valves, artificial limbs or hands, brain stimulator devices, implanted drug pumps, ear implants, eye implants or known metal fragments in eyes, exposure to shrapnel or metal filings (wounded in military combat, sheet metal workers, welders, and others), other metallic surgical hardware in vital areas, certain tattoos with metallic ink, certain transdermal medication patches, and metal-containing IUDs

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Primary Purpose
Basic Science
Masking
Single (Participant)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Hypoglycemia
Participants undergo Autonomic Nervous System (ANS) Testing (measurement of Baroreflex Sensitivity using the Modified Oxford test) followed by a functional MRI (fMRI) scan. The next day, participants undergo one 120-minute hypoglycemic hyperinsulinemic clamp procedure (50mg/dL) in the morning followed by ANS Testing and an fMRI scan. Four days later, participants undergo repeat ANS Testing and an fMRI scan.
  • Other: Hypoglycemic Hyperinsulinemic Clamp
    Participants undergo a 120-minute hypoglycemic hyperinsulinemic clamp procedure.
    Other names:
    • Hypoglycemic Hyperinsulinemic Clamp Procedure
Placebo Comparator
Normoglycemia
Participants undergo Autonomic Nervous System (ANS) Testing (measurement of Baroreflex Sensitivity using the Modified Oxford test) followed by a functional MRI (fMRI) scan. The next day, participants undergo one 120-minute normoglycemic hyperinsulinemic clamp procedure (90mg/dL) in the morning followed by ANS Testing and an fMRI scan. Four days later, participants undergo repeat ANS Testing and an fMRI scan.
  • Other: Normoglycemic Hyperinsulinemic Clamp
    Participants undergo a 120-minute normoglycemic hyperinsulinemic clamp procedure.
    Other names:
    • Normoglycemic Hyperinsulinemic Clamp Procedure

Recruiting Locations

Brigham and Women's Hospital
Boston, Massachusetts 02115
Contact:
Gail K Adler, MD, PhD
617-732-6660
gadler@partners.org

More Details

Status
Recruiting
Sponsor
Brigham and Women's Hospital

Study Contact

Gail K Adler, MD, PhD
617-732-8742
gadler@bwh.harvard.edu

Detailed Description

Stress is common in daily life and is associated with adverse health outcomes. This proposal will study how a physiological stress (low blood sugar), a stress often experienced by people with diabetes, affects connections in the brain. The investigators will focus on brain connections that are involved in autonomic control of cardiovascular function, and determine both how these brain connections are altered by low blood sugar and how these alterations associate with changes in pain perception and cardiovascular control. In this study, the investigators introduce a novel mechanistic, integrative approach to the assessment of the response to and recovery from a specific physiologic stressor - insulin-induced hypoglycemia. The overall hypothesis is that a hypoglycemic stress will alter autonomic brain networks, and will affect clinically relevant physiological outcomes (cardiovascular autonomic function); and that the rate and extent of recovery of these brain networks will provide a measure of resilience. In combination, this approach will allow the investigators for the first time to define the magnitude of the effect of stress exposure on neural circuitry and on clinically relevant stress-related physiological outcomes (cardiovascular autonomic function) and to define the recovery of brain circuitry and these related physiological outcomes.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.